Incidence, Predictors, and Mid-Term Outcomes of Possible Leaflet Thrombosis After TAVR

JACC: Cardiovascular Imaging

Volumn 10, Issue 1, 2017, Pages 1-11

  Yanagisawa, Ryo ^a   Hayashida, Kentaro ^a   Yamada, Yoshitake ^a   Tanaka, Makoto ^a   Yashima, Fumiaki ^a   Inohara, Taku ^a   Arai, Takahide ^a   Kawakami, Takashi ^a   Maekawa, Yuichiro ^a   Tsuruta, Hikaru ^a   Itabashi, Yuji ^a   Murata, Mitsushige ^a   Sano, Motoaki ^a   Okamoto, Kazuma ^a   Yoshitake, Akihiro ^a   Shimizu, Hideyuki ^a   Jinzaki, Masahiro ^a   Fukuda, Keiichi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

aortic stenosis; D dimer; reduced leaflet motion; TAVR; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; BRAIN NATRIURETIC PEPTIDE; CLOPIDOGREL; DABIGATRAN; IOPAMIDOL; RIVAROXABAN;

AGED; ANTICOAGULANT THERAPY; AORTA SINUS; AORTA THROMBOSIS; AORTA VALVE; AORTA VALVE DISEASE; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HEART VALVE BIOPROSTHESIS; HOSPITAL DISCHARGE; HUMAN; HYPOATTENUATED LEAFLET THICKENING; IMMOBILITY; INCIDENCE; LABORATORY TEST; LEAFLET THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OUTCOME ASSESSMENT; PERCUTANEOUS AORTIC VALVE; PRESSURE GRADIENT; PRIORITY JOURNAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION;

EID: 85009094275     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2016.11.005     Document Type: Article

References (26)

1. 1 Leon, M.B., Smith, C.R., Mack, M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363 (2010), 1597–1607.
2. 2 Lefevre, T., Kappetein, A.P., Wolner, E., et al. One-year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 32 (2010), 148–157.
3. 3 Smith, C.R., Leon, M.B., Mack, M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364 (2011), 2187–2198.
4. 4 Makkar, R.R., Fontana, G.P., Jilaihawi, H., et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366 (2012), 1696–1704.
5. 5 Adams, D.H., Popma, J.J., Reardon, M.J., et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370 (2014), 1790–1798.
6. 6 Kapadia, S.R., Leon, M.B., Makkar, R.R., et al. 5-Year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385 (2015), 2485–2491.
7. 7 Mack, M.J., Leon, M.B., Smith, C.R., et al. 5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385 (2015), 2477–2484.
8. 8 Latib, A., Naganuma, T., Abdel-Wahab, M., et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv, 8, 2015, e001779.
9. 9 Pache, G., Blanke, P., Zeh, W., Jander, N., Cusp thrombosis after transcatheter aortic valve replacement detected by computed tomography and echocardiography. Eur Heart J, 34, 2013, 3546.
10. 10 Pingpoh, C., Pache, G., Nawras, D., et al. Valve thrombosis 7 months after transcatheter aortic valve implantation. Ann Thorac Surg 98 (2014), 1079–1081.
11. 11 De Marchena, E., Mesa, J., Pomenti, S., et al. Thrombus formation following transcatheter aortic valve replacement. J Am Coll Cardiol Intv 8 (2015), 728–739.
12. 12 Latib, A., Messika-Zeitoun, D., Maisano, F., et al. Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. J Am Coll Cardiol 61 (2013), 787–789.
13. 13 Egbe, A.C., Pislaru, S.V., Pellikka, P.A., et al. Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors. J Am Coll Cardiol 66 (2015), 2285–2294.
14. 14 Makkar, R.R., Fontana, G., Jilaihawi, H., et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 373 (2015), 2015–2024.
15. 15 Mylotte, D., Piazza, N., Transcatheter aortic valve replacement failure: deja vu ou jamais vu?. Circ Cardiovasc Interv, 8, 2015, e002531.
16. 16 Pache, G., Schoechlin, S., Blanke, P., et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J 37 (2016), 2263–2271.
17. 17 Yamada, Y., Jinzaki, M., Hosokawa, T., et al. Dose reduction in chest CT: comparison of the adaptive iterative dose reduction 3D, adaptive iterative dose reduction, and filtered back projection reconstruction techniques. Eur J Radiol 81 (2012), 4185–4195.
18. 18 Leetmaa, T., Hansson, N.C., Leipsic, J., et al. Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography. Circ Cardiovasc Interv, 8, 2015, e001596.
19. 19 Schoechlin, S., Ruile, P., Neumann, F.J., Pache, G., Early hypoattenuated leaflet thickening and restricted leaflet motion of a Lotus transcatheter heart valve detected by 4D computed tomography angiography. EuroIntervention, 11, 2015, e1.
20. 20 Masri, A., Schoenhagen, P., Svensson, L., et al. Dynamic characterization of aortic annulus geometry and morphology with multimodality imaging: predictive value for aortic regurgitation after transcatheter aortic valve replacement. J Thoracic Cardiovasc Surg 147 (2014), 1847–1854.
21. 21 Kappetein, A.P., Head, S.J., Genereux, P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 145 (2013), 6–23.
22. 22 Pibarot, P., Dumesnil, J.G., Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 119 (2009), 1034–1048.
23. 23 Jilaihawi, H., Doctor, N., Chakravarty, T., et al. Major thrombocytopenia after balloon-expandable transcatheter aortic valve replacement: prognostic implications and comparison to surgical aortic valve replacement. Catheterization and Cardiovascular Interventions 85 (2015), 130–137.
24. 24 Brennan, J.M., Edwards, F.H., Zhao, Y., et al. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. J Am Coll Cardiol 60 (2012), 971–977.
25. 25 Messika-Zeitoun, D., Serfaty, J.M., Brochet, E., et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol 55 (2010), 186–194.
26. 26 Gündüz, S., Özkan, M., Kalçik, M., et al. Sixty-four-section cardiac computed tomography in mechanical prosthetic heart valve dysfunction: thrombus or pannus. Circulation Cardiovascular Imaging, 8, 2015, e003246.